Craig Astill on Global Health and Agriculture Investment

With a career spanning more than thirty years in international trade, investment and project development, Craig Astill has entered the keynote and panel circuit in a new phase: sharing hard-earned insights from his time as managing director and chief executive of Caason Group.

In late October 2025 he addressed two high-level gatherings hosted by the Global Investment Leaders Club: the “242nd Healthcare Investors Alliance” and the “241st AgTech Investors’ Alliance”, both held virtually.

The healthcare forum
At the October 30 event focused on healthcare investment, Mr. Astill spoke to an audience of senior investors, family-office principals and founders about the parallels between emerging medical-tech ventures and the resource- and ag-business models he knows well. He offered reflections on scaling innovation, underwriting regulatory risk and forging global networks — themes that have defined much of his professional life.

The agriculture/food-tech session
Just days earlier, at the agriculture-tech event, Mr. Astill drew on his experience with Caason’s agribusiness investments, including large-scale pastoral holdings and industrial-hemp projects. He emphasised that today’s ag-tech pioneers must confront provenance, data-intensive farming and global supply-chain traceability — factors he says have long been underappreciated in traditional commodity models.

A career built on partnerships and execution
Mr. Astill founded Caason Group in 1999, bringing together interests in trade, finance, mining, agribusiness and innovation. His early work included exporting perishable dairy products in large volumes to the Middle East and North Africa, and co-authoring patents for cross-border business processes. Over time, he expanded into major agribusiness holdings, environmental technologies and fintech ventures.

By speaking at the GILC forums, Mr. Astill signals a new chapter: one in which he is not only an investor and operator, but also a mentor and thought-leader. Through these events he seeks to bridge sectors — bringing resource-industry discipline to health-care investment, and tech-driven farming to global ag-markets.

What this means for investors and founders
In health care, Mr. Astill cautions that success depends on more than scientific promise. “It’s about regulatory rhythm, scaling and global access,” he told attendees (audio and slides made available by the organising body). For ag-tech, he emphasised that the current wave of interest demands real-world proof, not hype: traceability, sustainability and nutrient value matter as much as algorithmic efficiency.

Looking ahead
Mr. Astill plans further speaking engagements throughout 2026, targeting forums in Asia, the United States and Europe. He says his goal is to help founders and investors apply cross-sector lessons: “I’ve been in agribusiness, mining, trade, technology — the cause I really value now is helping others connect the dots.”